| Jerome H Foti, RPH | |
|
302 Dulles Dr, Lafayette, LA 70506-3008 | |
| (337) 262-4100 | |
| (337) 262-1733 |
| Full Name | Jerome H Foti |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 302 Dulles Dr, Lafayette, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104952886 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11318 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jerome H Foti, RPH 302 Dulles Dr, Lafayette, LA 70506-3008 Ph: (337) 262-4100 | Jerome H Foti, RPH 302 Dulles Dr, Lafayette, LA 70506-3008 Ph: (337) 262-4100 |
News Archive
Scientists studying genetic data from nearly 50,000 people have uncovered several DNA sequence variations associated with the electrical impulses that make the heart beat. The findings, reported in Nature Genetics, may pave the way for a greater understanding of the mechanisms for abnormal heart rhythms and sudden cardiac death.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
On the spending side, the president's plan takes a sensible approach toward saving money in Medicare and Medicaid. More than 90 percent of the $248 billion in Medicare cuts over 10 years would come from reducing payments to drug companies and health care providers that are unnecessarily high.
Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in patients with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance can be safely delayed or avoided in these patients. Full findings are published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
Hi-Tech Pharmacal Co., Inc. announced today that its branded marketing subsidiary, ECR Pharmaceuticals will promote Urocit®-K 15mEq, potassium citrate extended release tablets to primary care physicians beginning in April, 2010. Hi-Tech has a license agreement with Mission Pharmacal Company, which will promote the product to Urologists.
› Verified 5 days ago
Philip Asare, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2517 Kaliste Saloon Rd, Lafayette, LA 70508 Phone: 337-216-9187 | |
Tammie Koelz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 Johnston St, Suite 200, Lafayette, LA 70503 Phone: 337-234-0197 Fax: 337-234-6939 | |
Dr. Jami Jenkins, PHARMD,RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3142 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-989-4095 | |
Jude K Fuselier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Johnston St, Lafayette, LA 70503 Phone: 337-988-7284 | |
Tuan Tran, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Johnston St, Lafayette, LA 70503 Phone: 337-232-9317 | |
Ellis Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-470-5500 | |
Mr. Christopher Jude Morrow, R.PH., BSPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3747 Moss St, Lafayette, LA 70507 Phone: 337-291-1808 |